Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-DEXTROAMPHETAMINE SR DIN 02481472

Status: Approved
Holder: APOTEX INC
Molecule: DEXTROAMPHETAMINE SULFATE

Health Canada record

Active ingredient(s)DEXTROAMPHETAMINE SULFATE 15 MG
Dosage formCapsule (Sustained-Release)
RouteOral
ScheduleCONTROLLED DRUGS (CDSA I)
ClassHuman
ATCN06BA02 DEXAMFETAMINE
Original market date
Current status date09-Oct-2018
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DEXTROAMPHETAMINE SULFATE

DINProductCompanyFormStrengthStatus
02481464APO-DEXTROAMPHETAMINE SRAPOTEX INCCapsule (Sustained-Release)DEXTROAMPHETAMINE SULFATE 10 MGApproved
01924516DEXEDRINEKNIGHT THERAPEUTICS INC.TabletDEXTROAMPHETAMINE SULFATE 5 MGMarketed
01924559DEXEDRINE SPANSULEKNIGHT THERAPEUTICS INC.Capsule (Sustained-Release)DEXTROAMPHETAMINE SULFATE 10 MGMarketed
01924567DEXEDRINE SPANSULEKNIGHT THERAPEUTICS INC.Capsule (Sustained-Release)DEXTROAMPHETAMINE SULFATE 15 MGMarketed
02443236DEXTROAMPHETAMINEAA PHARMA INCTabletDEXTROAMPHETAMINE SULFATE 5 MGMarketed
02566605PMS-DEXTROAMPHETAMINEPHARMASCIENCE INCTabletDEXTROAMPHETAMINE SULFATE 5 MGApproved
02448327TEVA-DEXTROAMPHETAMINE SRTEVA CANADA LIMITEDCapsule (Sustained-Release)DEXTROAMPHETAMINE SULFATE 15 MGMarketed
02448319TEVA-DEXTROAMPHETAMINE SRTEVA CANADA LIMITEDCapsule (Sustained-Release)DEXTROAMPHETAMINE SULFATE 10 MGMarketed
02447673PMS-DEXTROAMPHETAMINEPHARMASCIENCE INCTabletDEXTROAMPHETAMINE SULFATE 5 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
214042018-10-09Abbreviated New Drug Submission (ANDS)

International API supply for DEXTROAMPHETAMINE SULFATE

8 active FDA Drug Master Files.

Request a quote for APO-DEXTROAMPHETAMINE SR

How to read a Canadian DIN record